| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,033 |
3,207 |
$99K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
890 |
800 |
$24K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
900 |
503 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,127 |
565 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
888 |
694 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
716 |
562 |
$5K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
364 |
321 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
68 |
63 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
57 |
48 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
360 |
328 |
$383.66 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
16 |
$356.39 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
95 |
90 |
$319.67 |
| 81002 |
|
67 |
65 |
$20.53 |
| 99000 |
|
78 |
75 |
$0.29 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
13 |
12 |
$0.00 |